Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation.

Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation.

Using various mutants of p53 and mdm2, we demonstrate here that both the DNA binding and transactivation function of p53 are required for ASPP1 and ASPP2 to stimulate the apoptotic functions of p53. Mdm2 and mdmx prevent ASPP1 and ASPP2 from stimulating the apoptotic function of p53 by binding and i...

Descrición completa

Detalles Bibliográficos
Main Authors:	Bergamaschi, D, Samuels, Y, Zhong, S, Lu, X
Formato:	Journal article
Idioma:	English
Publicado:	2005

Títulos similares

Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
por: Zuzana Mrkvová, et al.
Publicado: (2019-06-01)

ASPP1 and ASPP2: common activators of p53 family members.
por: Bergamaschi, D, et al.
Publicado: (2004)

Controlling the Mdm2-Mdmx-p53 Circuit
por: David L. Waning, et al.
Publicado: (2010-05-01)

Molecular mechanism of CCDC106 regulating the p53-Mdm2/MdmX signaling axis
por: Ting Zhou, et al.
Publicado: (2023-12-01)

p53 Phosphomimetics Preserve Transient Secondary Structure but Reduce Binding to Mdm2 and MdmX
por: Robin Levy, et al.
Publicado: (2019-03-01)

ASPP proteins specifically stimulate the apoptotic function of p53.
por: Samuels-Lev, Y, et al.
Publicado: (2001)

MDM2 and MDMX bind and stabilize the p53-related protein p73
por: Ongkeko, W, et al.
Publicado: (1999)

Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network.
por: Lilyn Daftuar, et al.
Publicado: (2013-01-01)

ASPP--Apoptotic specific regulator of p53.
por: Liu, Z, et al.
Publicado: (2005)

Small Molecule Inhibitors of MDM2-p53 and MDMX-p53 Interactions as New Cancer Therapeutics
por: Yujun Zhao, et al.
Publicado: (2013-07-01)

Predicted functions of MdmX in fine-tuning the response of p53 to DNA damage.
por: Sohyoung Kim, et al.
Publicado: (2010-02-01)

ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells
por: Wang, Y, et al.
Publicado: (2013)

ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells.
por: Wang, Y, et al.
Publicado: (2013)

Insight Into the Binding Mechanism of p53/pDIQ-MDMX/MDM2 With the Interaction Entropy Method
por: Mengxin Li, et al.
Publicado: (2019-01-01)

The role of p53 and ASPP2 in neurodegenerative disease
por: Turnquist, C
Publicado: (2015)

Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.
por: Lu, M, et al.
Publicado: (2013)

Correction: restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP
por: Lu, M, et al.
Publicado: (2016)

A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein.
por: Georgios Valianatos, et al.
Publicado: (2017-01-01)

Synthesis and Biological Evaluation of Novel Synthetic Indolone Derivatives as Anti-Tumor Agents Targeting p53-MDM2 and p53-MDMX
por: Yali Wang, et al.
Publicado: (2022-06-01)

Energetic Landscape of MDM2-p53 Interactions by Computational Mutagenesis of the MDM2-p53 Interaction.
por: Kelly M Thayer, et al.
Publicado: (2016-01-01)

Stress-induced alternative splice forms of MDM2 and MDMX modulate the p53-pathway in distinct ways.
por: Aishwarya G Jacob, et al.
Publicado: (2014-01-01)

Regulation of immunological tolerance by the p53-inhibitor iASPP
por: Akama-Garren, EH, et al.
Publicado: (2023)

iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human.
por: Bergamaschi, D, et al.
Publicado: (2003)

Regulation of immunological tolerance by the p53-inhibitor iASPP
por: Elliot H. Akama-Garren, et al.
Publicado: (2023-02-01)

iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53.
por: Bergamaschi, D, et al.
Publicado: (2006)

Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?
por: Si-Min Qi, et al.
Publicado: (2020-04-01)

MDMX is essential for the regulation of p53 protein levels in the absence of a functional MDM2 C-terminal tail
por: Jack D. Sanford, et al.
Publicado: (2021-09-01)

Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for P53 activation and tumor suppression
por: Xiang Li, et al.
Publicado: (2021-09-01)

Modulating the p53-MDM2 pathway
por: Iman Ramli, et al.
Publicado: (2024-11-01)

Detection of P53 and Mdm2 in vitiligo
por: Viroj Wiwanitkit
Publicado: (2013-01-01)

Evolution of the p53-MDM2 pathway
por: Emma Åberg, et al.
Publicado: (2017-08-01)

Mutational Analysis of ASPP1 and ASPP2 Genes, a p53-related Gene, in Gastric and Cololorectal Cancers with Microsatellite Instability
Publicado: (2010-06-01)

MDM2 inhibitors: Targeting p53-MDM2 interaction to anti-cancer
por: Zhang Xulin
Publicado: (2021-01-01)

Deletion of ASPP1 in myofibroblasts alleviates myocardial fibrosis by reducing p53 degradation
por: Shangxuan Li, et al.
Publicado: (2024-09-01)

The ASPP proteins complex and cooperate with p300 to modulate the transcriptional activity of p53
por: Gillotin, S, et al.
Publicado: (2011)

The ASPP proteins complex and cooperate with p300 to modulate the transcriptional activity of p53.
por: Gillotin, S, et al.
Publicado: (2011)

ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growth.
por: Vives, V, et al.
Publicado: (2006)

Hinokiflavone Inhibits MDM2 Activity by Targeting the MDM2-MDMX RING Domain
por: Viktoria K. Ilic, et al.
Publicado: (2022-04-01)

The dual interactions of p53 with MDM2 and p300 : implications for the design of MDM2 inhibitors
por: Kannan, Srinivasaraghavan, et al.
Publicado: (2020)

Mdm2 targets the p53 transcription cofactor JMY for degradation.
por: Coutts, A, et al.
Publicado: (2007)